NCT00636090View on ClinicalTrials.gov

Molecular, Genetic, and Genomic Assessments From Patients Treated With RAD001

CompletedOBSERVATIONAL

Enrollment

35

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

December 31, 2009

Study Completion Date

January 31, 2010

Conditions

Metastatic Hormone Refractory Prostate Cancer

Trial Locations (1)

27710

Duke University Medical Center, Durham

Sponsors

Lead Sponsor

Duke University

All Listed Sponsors

collaborator

United States Department of Defense

FED

lead

Duke University

OTHER

NCT00636090 - Molecular, Genetic, and Genomic Assessments From Patients Treated With RAD001 | Biotech Hunter | Biotech Hunter